Kazda A.1, 2, Valenta J.3, Brodská H.2, Stach Z.3, Hendl, J.4, Stříteský, M.3:
	 
        
         
        
        Procalcitonin in Critically Ill Patients 
        
          | 
    
	4 | 
  
  
    
	
	Beránek M., Voborníková J., Hypiusová V., Palička V.:
	 
        
         
        
        MagNA Pure System for DNA Extraction
from Whole Blood Clinical
Verification of Pre-Analytical Phase of DNA Testing 
        
        Fulltext 
        
          | 
    
	10 | 
  
  
    
	
	Friedecký B., Vávrová J.:
	 
        
         
        
        Precision, Bias, Comparability and Uncertainty of Protein Measurement by CZE Paragon 2000 
        
          | 
    
	14 | 
  
  
    
	
	Stibůrková B.1, Šebesta I.1, 4, Pospíšilová E.1, Šťastná S.1, Kumšta M.4, Zeman J.1, Kmoch S.1, 2:
	 
        
         
        
        Differential Diagnostics of
Hyperuricaemia in Hereditary Metabolic Diseases 
        
          | 
    
	18 | 
  
  
    
	
	Cibulka R.:
	 
        
         
        
        Metabolic Effects of Carnitine and its Role in Medicine 
        
          | 
    
	24 | 
  
  
    
	
	Cibulka R.1, Racek J.1, Trefil L.1, Veselá E.2, Studenovská M.3, Rajdl D.1:
	 
        
         
        
        Deficit of L-carnitine in Haemodialysis Patients
and a Potential Role of its Suplementation 
        
          | 
    
	29 | 
  
  
    
	
	Schück O.1, Matoušovic, K.2:
	 
        
         
        
        Relation between pH and Strong Ion Difference (SID) in Body Fluids 
        
        Fulltext 
        
          | 
    
	32 | 
  
  
    
	
	Rajdl D.1, Racek J.1, Steinerová A.2, Stožický F.3, Trefil L.1, Korotvička M.2, Rokyta Z.4:
	 
        
         
        
        Selected Risk Factors of Atherosclerosis
and Breast Feeding 
        
          | 
    
	36 | 
  
  
    
	
	Bajgar J.:
	 
        
         
        
        Laboratory Diagnosis
of Organophosphates/Nerve Agent Poisoning 
        
        Fulltext 
        
          | 
    
	40 | 
  
  
    
	
	Matl I.1, Viklický O.1, Teplan V.1, Voska L.2, Lánská V.2:
	 
        
         
        
        Hyperlipidemia in Kidney Transplant Patients Treated with
Immunosuppression with Cyclosporine or Tacrolimus 
        
        Fulltext 
        
          | 
    
	48 |